Clinical study on gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid enhanced magnetic resonance imaging for assessing liver function in patients with chronic hepatitis B
Objective:To study the performance of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid(Gd-EOB-DTPA)enhanced magnetic resonance imaging(MRI)for assessing liver function in patients with chronic hepatitis B(CHB).Methods:60 patients with CHB were included in this prospective study from Oct.1,2022 to Dec.10,2023.Gd-EOB-DTPA enhanced MRI was conducted,and then the signal intensity ratio(SIR)and con-trast enhancement index(CEI)for each phase were calculated.SIR and CEI were compared with Child-Pugh grad-ing,real-time shear wave elastography(SWE)and non-invasive liver fibrosis models including APRI,FIB-4,GPR.Results:SWE(P<0.001),SIR(P =0.005)and CEI(P =0.003)in the liver biliary phase(HBP),FIB-4(P<0.001)showed statistical differences in different Child-Pugh grades.Statistically significant differences were found in SIRHBP(P =0.031),CEIHBP(P =0.001)and FIB-4(P<0.001)of different SWE levels.SWE showed signifi-cant differencesbetween the low-level CEIHBPand the medium-level CEIHBP(P =0.017)as well as high-level CEIHBP(P =0.022).Child-Pugh levels showed differences among different CEIHBP group(P =0.011).A negative correla-tion was found between CEIHBPand SWE(r =-0.397 3,P =0.001 7).The area under the curve(AUC)of the CEIHBP level for Child Pugh B +C grade was 0.720,the sensitivity and specificity were 0.818 and 0.605,respec-tively.Conclusion:Gd-EOB-DTPA enhanced MRI is an effective method for evaluating liver function in patients with CHB.CEIHBP couldquantitatively measure liver function.
magneticresonance imaginggadolinium ethoxybenzyl diethylenetriamine pentaacetic acidchronic hepatitis Bliver function